About Event
Welcome to the 3rd Next Generation RNA Therapeutics Summit
Addressing key challenges such as next generation RNA sequence design, purity, stability, safety and translatability into clinical settings, the 2024 summit addressed burning questions such as:
Navigating the intricate landscape of circular RNA production, encompassing manufacturing challenges such as yield, scalability, and purity to ensure the production of exceptional circular RNA therapeutics
Fostering collaboration and bolstering the advancement of emerging innovations in circular RNA, transfer RNA, and self-amplifying RNA technologies by forging connections between pharmaceutical companies, biotech firms, and investors
Enhancing delivery platforms for next generation RNA therapeutics and overcoming targeted delivery hurdles including stability, cellular uptake, and tissue specificity to unlock therapeutic efficacy
As the industry’s only forum solely dedicated to exhibiting advances in this novel class of RNA medicines, the 2024 agenda boasted 20+ strategic sessions from leading RNA stakeholders. This was a unique opportunity to hear CXOs discuss investment and collaboration, and 3 interactive workshops delving into Delivery, CMC and Purification Challenges.
100+ expert leaders explored pioneering advances in RNA technologies, spanning CXOs, VPs, Directors and Scientists with expertise in Discovery, Delivery, R&D, Manufacturing, and Preclinical Translation, as we continue to fast-track these new RNA modality therapies into the clinic, and towards patients faster.
What You Missed in 2024:
100+
Attendees
22+
Expert Speakers
1
Panel Discussions
2
Interactive Fireside Chats
